Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Dundee Corp T.DC.A

Alternate Symbol(s):  DDEJF

Financial Services Healthcare Technology Asset Management Gold Silver
Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include mining investments, mining services, and corporate and others. Its asset base includes investments in precious and base metals projects across four continents. Its subsidiaries include Dundee... see more

TSX:DC.A - Post Discussion

Dundee Corp > Taurx
View:
Post by valueinvestor89 on Feb 05, 2024 6:12am

Taurx

https://www.businesswire.com/news/home/20240205168572/en/TauRx-to-Present-Two-Year-Data-from-Phase-III-Trial-of-HMTM-in-Alzheimer’s-Disease-at-the-ADPD™-2024-Conference-in-March
Comment by TheCount11 on Feb 05, 2024 9:55am
Thank you!  Amazing news! "TauRx has initiated regulatory engagement in the UK and the US for intended product approval. Other territories will follow in line with plans to scale commercialisation of HMTM."
Comment by Catscratch on Feb 05, 2024 12:14pm
Curious to see how Genting's stock reacts to this news.
Comment by pierrelebel on Feb 05, 2024 4:13pm
Genting was up two cents on the day.  No big deal as this is nothing new: same old... same old.
Comment by Catscratch on Feb 06, 2024 9:00am
Agree.  Nothing new.  Perhaps with a regulatory approval there will be some reaction.
Dundee Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities